|
Re: Why is "Going it Alone" out of the question??
|
5
|
Resverlogix Corp.
|
Aug 14, 2020 06:38PM
|
|
Re: Data highlights
|
5
|
Resverlogix Corp.
|
Nov 16, 2019 05:38PM
|
|
Re: Trial delay
|
5
|
Resverlogix Corp.
|
May 04, 2021 07:21PM
|
|
Fiercemarkets article
|
5
|
Resverlogix Corp.
|
Mar 23, 2021 11:10AM
|
|
Re: December 22, 2020.
|
5
|
Resverlogix Corp.
|
Oct 11, 2020 04:36PM
|
|
Re: H1 2020 Potential Events
|
5
|
Resverlogix Corp.
|
Mar 10, 2020 07:54AM
|
|
Re: Where is the trial?
|
5
|
Resverlogix Corp.
|
Apr 23, 2021 03:28PM
|
|
Re: As Pfizer charges ahead....
|
5
|
Resverlogix Corp.
|
Sep 07, 2021 07:22PM
|
|
Synairgen
|
5
|
Resverlogix Corp.
|
Jul 20, 2020 07:25AM
|
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 05:16PM
|
|
Re: Please help
|
5
|
Resverlogix Corp.
|
Apr 02, 2021 08:12PM
|
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 05:16PM
|
|
Re: Where is the trial?
|
5
|
Resverlogix Corp.
|
Apr 23, 2021 05:04PM
|
|
Re: Australia Associated Press
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 05:43PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
5
|
Resverlogix Corp.
|
Mar 26, 2020 06:08PM
|
|
Re: Australia Associated Press
|
5
|
Resverlogix Corp.
|
Mar 03, 2021 05:48PM
|
|
Re: Bringing us back on track
|
5
|
Resverlogix Corp.
|
Mar 01, 2020 10:22AM
|
|
Re: Corona- COVID-19
|
5
|
Resverlogix Corp.
|
Mar 05, 2020 06:58PM
|
|
Re: Breakthrough Therapy Designation Application
|
5
|
Resverlogix Corp.
|
Dec 06, 2019 10:44AM
|
|
Re: If BP buys Apabetalone,...
|
5
|
Resverlogix Corp.
|
Nov 05, 2019 09:11PM
|
